Linda Russell gives an independent comment on a study showing that suspending bisphosphonate treatment for more than 2 years is associated with increased fracture risk.
08-11-2017 | Osteoporosis | ACR/ARHP 2017 | Video
08-11-2017 | Osteoporosis | ACR/ARHP 2017 | Video
Linda Russell gives an independent comment on a study showing that suspending bisphosphonate treatment for more than 2 years is associated with increased fracture risk.